课题基金 / 基金详情

Discovery and development of new biocatalysts to efficiently access bioactive targets

Discovery and development of new biocatalysts to efficiently access bioactive targets
发现和开发新的生物催化剂以有效地获得生物活性目标
批准号:
2132560
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
通过跨学科的方法,我们的最终目标是利用大自然的生物合成机制,从简单的原料中生产出多种高价值的生物活性化合物。PKS/NRPS支架生物合成的模块化以及剪裁酶的大量组装后修饰为创造具有优化性能和生产的新化合物提供了前景,本提案的重点是发现和开发新生物催化剂。酶催化的反应具有很高的选择性,一般来说,这是标准化学反应无法模拟的。虽然生物转化通常用于简单的分解(例如使用酰化酶),还原以及最近的醛化学,但仍有大量酶催化的转化尚未被用于清洁和有效地生产生物活性支架。该项目将从探索我们最近分离的酶的生物催化潜力开始,以期利用它们在工业相关过程中的独特能力。例如,使用x射线晶体结构、酶测定和分子模型的组合,我们已经提供了Diels-Alderase (AbyU)在抗生素阿比索菌素的生物合成中的证据。化学。Soc。, 2016)。我们将研究分子间和分子内的DA反应,以及使用可能形成多个环的底物(例如,使用参与抗生素四环十霉素生物合成的类似物)的AbyU的选择性。进一步的酶在阿比索菌素途径已被表征。这些酶的底物特异性也将被探索,其活性位点的工程将通过分子建模得到一系列具有潜在抗生素活性的非天然线性四酸盐。所有新化合物都将经过生物活性筛选。许多生物活性化合物被组装在氧杂环上,6元环四氢吡喃(THPs)和5元四氢呋喃(THFs)。在复杂的线性底物中,通过氧化未活化的甲基来选择性地产生这些环是非常困难的(可以说是不可能的)。然而,利用参与抗生素莫匹罗星生物合成的加氧酶进行的令人兴奋的初步体外研究表明,酶确实可以选择性地产生四氢呋喃和四氢呋喃。这些和其他有趣的生物转化的机制将被阐明和底物特异性探索。该项目将包括蛋白质化学(包括使用x射线晶体学的结构研究,最先进的核磁共振和质谱技术),新化合物的分离和结构确定以及分子建模。
英文摘要
Using an interdisciplinary approach, our ultimate goal is to produce a multiplicity of high valuebiologically active compounds from simple feed-stocks by exploiting Nature's biosynthetic machinery.The modularity of the PKS/NRPS scaffold biosynthesis together with the plethora of post assemblymodifications of tailoring enzymes offer prospects of creating novel compounds with optimizedproperties and production and the focus of this proposal is the discovery and exploitation of novelbiocatalysts. Enzymes catalyze reactions with exquisite selectivity which, in general, simply cannot beemulated using standard chemical reactions. Whilst biotransformations are commonly used for simpleresolutions (e.g. using acylases), reductions and more recently in aldol chemistry, there are a plethoraof enzyme-catalyzed transformations which have yet to be exploited for the clean and efficientproduction of bioactive scaffolds. The project will begin by exploring the biocatalytic potential ofenzymes which we have recently isolated with a view to exploiting their unique capabilities inindustrially relevant processes. For example, using a combination of X-ray crystal structures, enzymeassays and molecular modeling, we have provided evidence for a Diels-Alderase (AbyU) in thebiosynthesis of the antibiotic abyssomicin (J. Am. Chem. Soc., 2016). We will investigate both interandintramolecular DA reactions as well as the selectivity of AbyU using substrates with the potentialof forming more than one ring (e.g. using analogues involved in the biosynthesis of the antibiotictetrodecamycin). Further enzymes on the abyssomicin pathway have been characterized. Thesubstrate specificities of these enzymes will also be explored and engineering of their active sites willbe informed by molecular modeling leading to a series of non-natural linear tetronates with potentialantibiotic activity. All new compounds will undergo screening for biological activity. Many bioactivecompounds are assembled on oxygen heterocycles, 6-membered ring tetrahydropyrans (THPs) and 5-membered tetrahydrofurans (THFs). The selective creation of these rings via oxidation of un-activatedmethyl groups in complex linear substrates would be very difficult (arguably impossible) to achievechemically. However exciting preliminary in vitro studies using oxygenases involved in the biosynthesisthe antibiotic mupirocin have shown that enzymes can indeed be used to selectively generate eitherTHFs of THPs. The mechanisms of these and other intriguing biotransformations will be elucidated andthe substrate specificities explored. The project will include protein chemistry (including structuralstudies using X-ray crystallography, state-of the-art NMR and MS techniques), isolation and structuredetermination of novel compounds and molecular modeling.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
  • 批准号:
    82371668
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    乔云波
  • 依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
  • 批准号:
    82371276
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    严佳
  • 依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位: